Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Griffith, B. Brown-Elliott, S. Shepherd, J. Philley, R. Wallace (Tyler, United States Of America). Therapeutic outcomes for cavitary Mycobacterium avium complex (MAC) lung disease. Eur Respir J 2012; 40: Suppl. 56, 4372

Member's Comments

No comment yet.

Related content which might interest you: The emerging problem of treating pulmonary M. avium complex (MAC) disease – microbial substitution of MAC to M. abscessus, Scedosporium and Nocardia after multi-drug chemotherapy in pulmonary MAC disease Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 The relationship between Mycobacterium avium complex infection and aspergillus lung disease in bronchiectasis Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Is pulmonary rehabilitation (PRP) effective in restrictive lung disease (RLD)? Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004 Clinical utility of serum anti-mycobacterium avium complex (MAC) antibody for diagnosis of MAC lung disease in asymptomatic patients with radiologically suspected MAC lung disease: A pilot study Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 Pulmonary rehabilitation (PR) outcomes in chronic obstructive pulmonary disease (COPD) compared with interstitial lung disease (ILD) Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011 Diffuse lung disease in infancy: a working classification of the pediatric interstitial lung disease (pILD) multidisciplinary cooperative group Source: Eur Respir J 2005; 26: Suppl. 49, 500s Year: 2005 Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013 Effects of a combination of pulmonary rehabilitation (PR) and non invasive ventilation (NIV) in patients with advanced interstitial lung disease (ILD) Source: Annual Congress 2009 - Noninvasive ventilation in chronic respiratory failure Year: 2009 Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 Is it possible to predict the outcome of the whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP)? Source: International Congress 2015 – IIPs: orphan Year: 2015 Effects of pulmonary rehabilitation in patients with interstitial lung disease (ILD) Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation Year: 2009 Pulmonary tuberculosis presentation – Late diagnosis, advanced disease Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012 Pulmonary hypertension (PH) and features of pulmonary circulation in patient with lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 354s Year: 2006 Pulmonary rehabilitation in patients with interstitial lung disease – An useful therapeutic option? Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011 Rational for the new term paediatric diffuse parenchymal lung disease (DPLD) Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease Year: 2012 Pulmonary thromboembolism (PE) in patients with interstitial lung diseases (ILD) Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Pulmonary function response in smokers and patients with chronic obstructive lung disease (COPD) following exposure to concentrated fine (PM2.5) particles Source: Annual Congress 2009 - Indoor and outdoor air pollution Year: 2009 Treatment of suppurative lung disease Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=168 Year: 2004 Valvular bronchial blocking in the treatment of cavitary pulmonary tuberculosis (CPTB) Source: International Congress 2016 – Bronchoscopy: from diagnostic to treating air leaks Year: 2016 Impact of atelectasis on survival in emphysema patients treated with bronchoscopic lung volume reduction Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013